Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | = 56 % | Ability to promote tubulin polymerization relative to paclitaxel | ChEMBL. | 16870428 |
Activity (functional) | = 56 % | Ability to promote tubulin polymerization relative to paclitaxel | ChEMBL. | 16870428 |
Activity (functional) | = 68 % | Activity against human TK1 assessed as thymidine phosphorylation relative to thymidine | ChEMBL. | 16870428 |
Activity (functional) | = 68 % | Activity against human TK1 assessed as thymidine phosphorylation relative to thymidine | ChEMBL. | 16870428 |
EC50 (functional) | = 1.716 uM | Cytotoxicity against human MCF7 cells | ChEMBL. | 16870428 |
EC50 (functional) | = 1.716 uM | Cytotoxicity against human MCF7 cells | ChEMBL. | 16870428 |
EC50 (functional) | = 2.614 uM | Cytotoxicity against human HT29 cells | ChEMBL. | 16870428 |
EC50 (functional) | = 2.614 uM | Cytotoxicity against human HT29 cells | ChEMBL. | 16870428 |
EC50 (functional) | = 2.875 uM | Cytotoxicity against human K562 cells | ChEMBL. | 16870428 |
EC50 (functional) | = 2.875 uM | Cytotoxicity against human K562 cells | ChEMBL. | 16870428 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | 16870428 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.